CD38-targeting radioligand therapy

This page covers all CD38-targeting radioligand therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD38.

Targets

CD38

Phase 1 pipeline (1)

• Actinium Ac 225-DOTA-Daratumumab · City of Hope Medical Center · Oncology
  Targeting CD38 with a radioligand